Viridian Therapeutics, INC.\De (VRDN) — DEFA14A Filings
All DEFA14A filings from Viridian Therapeutics, INC.\De. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Viridian Therapeutics Files Proxy Materials
— Jun 10, 2024 Risk: low
Viridian Therapeutics, Inc. filed a Definitive Additional Materials proxy statement on June 10, 2024. This filing relates to the company's proxy materials, whic
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX